The Evolving Role of MRD in Managing Multiple Myeloma

Watchdoq November 18, 2024
(MedPage Today) -- Minimal residual disease (MRD) has emerged as a significant marker in the treatment of multiple myeloma (MM), allowing clinicians to make more informed decisions about therapy. MRD testing helps gauge the depth of treatment response...

Read Full Article